Rockland Trust’s Zimmer Biomet ZBH Stock Holding History

Rockland Trust’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,958	Closed	-$247K	–	167
2016 Q3	$247K	Buy	+1,958	New	+$242K	0.04%	141

Other funds holding ZBH

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Rockland Trust's ZBH Position: Q4 2016 in Review

Rockland Trust sold out of Zimmer Biomet (ZBH) in Q4 2016, closing a stake of 1,958 shares — an estimated $247K sold.

Rockland Trust first reported a position in ZBH in Q3 2016 and held it in 1 quarter. The position peaked at $247K in Q3 2016. 812 funds tracked by Wall St. Rank hold ZBH as of Q4 2016.

Rockland Trust reported no remaining Zimmer Biomet position as of Q4 2016 after selling out during the quarter.
Rockland Trust sold 1,958 Zimmer Biomet shares in Q4 2016, an estimated $247K.
Rockland Trust first reported a position in Zimmer Biomet in Q3 2016 and held it in 1 quarter.
Rockland Trust's Zimmer Biomet position peaked at $247K in Q3 2016.
812 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2016.

Based on Rockland Trust's 13F filing for Q4 2016, filed 30 Jan 2017.